ALT Stock Price | Altimmune Inc P/E, Revenue, EPS, & Forecasts

Altimmune Inc • ALT

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Altimmune Inc

Ticker

ALT

Trading on

NASDAQ

ISIN

US02155H2004

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Vipin K. Garg Ph.D.

Headquarters

910 Clopper Road, Gaithersburg, MD, United States, 20878

Employees

Website

https://altimmune.com

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Metrics

BasicAdvanced

Market cap

$284M

P/E ratio

EPS

-$1.26

Dividend Yield

0.00%

Beta

0.58

Forward P/E ratio

EBIDTA

$-98M

Ex dividend date

2017-01-20

Price & volume

Market cap

$284M

Average daily volume

10.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

14,193.73

Price to book

Earnings

EPS

-$1.26

EPS estimate (current quarter)

-$0.34

EPS estimate (next quarter)

-$0.33

EBITDA

$-98M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.58

52-week High

$11.16

52-week Low

$2.90

50-day moving average

$5.68

200-day moving average

$6.54

Short ratio

8.05

Short %

30.32%

Management effectiveness

ROE (TTM)

-57.28%

ROA (TTM)

-35.51%

Profit margin

0.00%

Gross profit margin

$-76.5M

Operating margin

-436,300.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

81.1M

Float

80.4M

Insiders %

0.76%

Institutions %

47.87%

Analyst Insights & forecasts

89% Buy

11% Hold

0% Sell

Based on information from 9 analysts.

Average price target

$20.63

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.35

-$0.34

-2.94%

Q2 • 24Missed

-$0.32

-$0.35

8.17%

Q3 • 24Beat

-$0.33

-$0.34

1.52%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-23.2M

-463,600.00%

Q4 • 24

$0M

$-19.6M

-391,500.00%

Q1 • 25

0.00%

-15.55%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$139M

$15.8M

11.34%

Q4 • 24

$157M

$15.1M

9.60%

Q1 • 25

12.89%

-4.41%

-15.33%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-18.3M

$13.6M

$10.1M

$-18.3M

Q4 • 24

$-16.8M

$-5.1M

$34.1M

$-16.8M

Q1 • 25

-7.80%

-137.42%

238.31%

-7.80%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Altimmune Inc share?

Altimmune Inc shares are currently traded for undefined per share.

How many shares does Altimmune Inc have?

Altimmune Inc currently has 81.1M shares.

Does Altimmune Inc pay dividends?

No, Altimmune Inc doesn't pay dividends.

What is Altimmune Inc 52 week high?

Altimmune Inc 52 week high is $11.16.

What is Altimmune Inc 52 week low?

Altimmune Inc 52 week low is $2.90.

What is the 200-day moving average of Altimmune Inc?

Altimmune Inc 200-day moving average is $6.54.

Who is Altimmune Inc CEO?

The CEO of Altimmune Inc is Dr. Vipin K. Garg Ph.D..

How many employees Altimmune Inc has?

Altimmune Inc has 59 employees.

What is the market cap of Altimmune Inc?

The market cap of Altimmune Inc is $284M.

What is the P/E of Altimmune Inc?

The current P/E of Altimmune Inc is null.

What is the EPS of Altimmune Inc?

The EPS of Altimmune Inc is -$1.26.

What is the PEG Ratio of Altimmune Inc?

The PEG Ratio of Altimmune Inc is 0.

What do analysts say about Altimmune Inc?

According to the analysts Altimmune Inc is considered a buy.